WuXi XDC, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in the field of Antibody-Drug Conjugates (ADC) and the broader bioconjugate market, has recently entered into a collaborative agreement with the Hong Kong Science and Technology Parks Corporation (HKSTP). This partnership aims to jointly advance the establishment of a comprehensive CRDMO value chain in Hong Kong.
This collaboration is intended to drive the development of ADCs and other bioconjugates in Hong Kong, utilizing WuXi XDC's extensive range of services and capabilities. The primary objective is to strengthen the biotechnology ecosystem in Hong Kong by fostering closer collaboration among industry players, academic institutions, and research organizations.
Under this agreement, companies within the HKSTP Park ecosystem will gain access to WuXi XDC's integrated platform, providing a one-stop solution for bioconjugate-based drug discovery, development, and analytical services. Additionally, WuXi XDC will offer consultation and training to biotechnology companies and research institutions in Hong Kong to expedite the transformation of scientific research findings into market-ready products.
Furthermore, HKSTP and WuXi XDC will deepen their collaboration by pooling resources and organizing joint activities. Together, they will outline a strategic roadmap to accelerate the establishment of a CRDMO value chain in Hong Kong. This, in turn, will streamline the drug development process and reduce the time required to bring innovative pharmaceutical products to market.
"We are delighted to partner with HKSTP to offer our one-stop platform, extensive industry expertise, and high-quality services to support local biotech firms. Hong Kong Science Park boasts a strong foundation in biotechnology with a focus on innovation. We are eager to solidify our partnership with HKSTP to drive the growth of the bioconjugate industry, ultimately benefiting patients worldwide."
"As the largest hub for technology research and development (R&D) and incubation in Hong Kong, HKSTP provides comprehensive state-of-the-art infrastructure and support services to the Innovation and Technology (I&T) ecosystem. We are excited to collaborate with WuXi XDC in assisting companies with technology transfer and expanding their market reach. By harnessing the strengths of both parties, we are committed to further enhancing the biotechnology ecosystem, positioning Hong Kong as a global hub for innovation and technology."
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!